Pular para o conteúdo
Doença de Charcot-Marie-Tooth tipo 4
ORPHA:64749CID-11 · 8C20.0DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
MuscularInício infânciaHerança AR
Também conhecida comoCMT4CMT 4CMTCMT1
Sinônimos clínicos: CMT4

A doença de Charcot-Marie-Tooth tipo 4 (CMT4) pertence ao grupo geneticamente heterogêneo de doenças de polineuropatia sensório-motora periférica da CMT.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A doença de Charcot-Marie-Tooth tipo 4 (CMT4) é uma condição genética rara que afeta os nervos periféricos que controlam a sensibilidade e os movimentos. Ela costuma se manifestar nos primeiros anos de vida, provocando fraqueza muscular nas mãos e pernas, atrofia dos músculos e alterações no formato dos pés, como pé torto. Também podem ocorrer dificuldades para caminhar, problemas respiratórios, alterações na fala e na visão. No Brasil, a CMT4 não possui um medicamento específico e não consta na lista oficial de PCDTs de doenças raras do Ministério da Saúde. O acompanhamento é feito pelo SUS para apoiar a mobilidade e cuidar dos sintomas ao longo do crescimento.

📋
Informacoes curadas por IA — podem conter imprecisoes

A doença de Charcot-Marie-Tooth tipo 4 (CMT4) pertence ao grupo geneticamente heterogêneo de doenças de polineuropatia sensório-motora periférica da CMT.

Publicações científicas
11 artigos
Último publicado: 2025 Sep

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Childhood
+ infancy
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

💪
Músculos
23 sintomas
🧠
Neurológico
23 sintomas
🦴
Ossos e articulações
12 sintomas
👁️
Olhos
12 sintomas
😀
Face
5 sintomas
👂
Ouvidos
5 sintomas

+ 89 sintomas em outras categorias

Características mais comuns

—
Atrofia do músculo esquelético
—
Fraqueza do músculo quadríceps
—
Defeito ventilatório restritivo
—
Coordenação motora grossa pobre
—
Marcha na ponta dos pés
—
Capacidade vital reduzida
173sintomas
Sem dados (173)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 173 características clínicas mais associadas, ordenadas por frequência.

Atrofia do músculo esqueléticoSkeletal muscle atrophy
Fraqueza do músculo quadrícepsQuadriceps muscle weakness
Defeito ventilatório restritivoRestrictive ventilatory defect
Coordenação motora grossa pobrePoor gross motor coordination

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico11PubMed
Últimos 10 anos9publicações
Pico20182 papers
Linha do tempo
2025Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

12 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

Curadoria gene-doença

fontes oficiais
PRX
PRX
EGR2E3 SUMO-protein ligase EGR2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (4)
Activation of anterior HOX genes in hindbrain development during early embryogenesisTranscriptional regulation of white adipocyte differentiationNGF-stimulated transcriptionEGR2 and SOX10-mediated initiation of Schwann cell myelination
MECANISMO DE DOENÇA

Neuropathy, congenital hypomyelinating, 1, autosomal recessive

A severe degenerating neuropathy that results from a congenital impairment in myelin formation. It is clinically characterized by early onset of hypotonia, areflexia, distal muscle weakness, and very slow nerve conduction velocities (as low as 3m/s). Some patients manifest nearly complete absence of spontaneous limb movements, respiratory distress at birth, and complete absence of myelin shown by electron microscopy of peripheral nerves.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
62.6 TPM
Linfócitos
32.8 TPM
Skin Not Sun Exposed Suprapubic
16.8 TPM
Skin Sun Exposed Lower leg
11.0 TPM
Pulmão
7.8 TPM
OUTRAS DOENÇAS (3)
Charcot-Marie-Tooth disease type 4ECharcot-Marie-Tooth disease type 1DCharcot-Marie-Tooth disease type 3
HGNC:3239UniProt:P11161
HK1Hexokinase-1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
GlycolysisSynthesis of GDP-mannose
MECANISMO DE DOENÇA

Anemia, congenital, non-spherocytic hemolytic, 5

An autosomal recessive disorder characterized by hemolytic anemia as the predominant clinical feature, and decreased red cell hexokinase activity.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
153.8 TPM
Cerebelo
139.0 TPM
Esôfago - Mucosa
123.5 TPM
Skin Sun Exposed Lower leg
114.2 TPM
Aorta
113.3 TPM
OUTRAS DOENÇAS (4)
neurodevelopmental disorder with visual defects and brain anomaliesretinitis pigmentosa 79non-spherocytic hemolytic anemia due to hexokinase deficiencyCharcot-Marie-Tooth disease type 4G
HGNC:4922UniProt:P19367
SH3TC2SH3 domain and tetratricopeptide repeat-containing protein 2Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 4C

A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. CMT4C is characterized by onset in childhood, early-onset scoliosis and a distinct Schwann cell pathology.

EXPRESSÃO TECIDUAL(Tecido-específico)
Nervo tibial
11.8 TPM
Brain Spinal cord cervical c-1
11.0 TPM
Testículo
9.3 TPM
Substância negra
3.3 TPM
Hipocampo
2.6 TPM
OUTRAS DOENÇAS (2)
Charcot-Marie-Tooth disease type 4Csusceptibility to mononeuropathy of the median nerve, mild
HGNC:29427UniProt:Q8TF17
SBF1Myotubularin-related protein 5Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Synthesis of PIPs at the ER membrane
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 4B3

A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
159.7 TPM
Tireoide
139.4 TPM
Cerebelo
137.9 TPM
Cérebro - Hemisfério cerebelar
114.5 TPM
Córtex cerebral
83.5 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (1)
Charcot-Marie-Tooth disease type 4B3
HGNC:10542UniProt:O95248
SBF2Myotubularin-related protein 13Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (2)
Synthesis of PIPs at the plasma membraneRAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 4B2

A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
33.1 TPM
Nervo tibial
29.2 TPM
Cervix Ectocervix
27.0 TPM
Ovário
23.8 TPM
Tecido adiposo
23.1 TPM
OUTRAS DOENÇAS (1)
Charcot-Marie-Tooth disease type 4B2
HGNC:2135UniProt:Q86WG5
FIG4Polyphosphoinositide phosphataseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Synthesis of PIPs at the Golgi membrane
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 4J

A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
25.0 TPM
Brain Frontal Cortex BA9
22.9 TPM
Aorta
22.2 TPM
Baço
20.8 TPM
Pituitária
20.7 TPM
OUTRAS DOENÇAS (5)
amyotrophic lateral sclerosis type 11Charcot-Marie-Tooth disease type 4Jbilateral parasagittal parieto-occipital polymicrogyriaYunis-Varon syndrome
HGNC:16873UniProt:Q92562
SURF1Surfeit locus protein 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Complex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 1

An autosomal recessive disorder of the mitochondrial respiratory chain characterized by early-onset, rapidly progressive encephalopathy, neurodegeneration, and loss of motor and cognitive skills. Affected individuals show hypotonia, failure to thrive, loss of the ability to sit or walk, poor communication, poor eye contact, oculomotor abnormalities, as well as deafness, ataxia, tremor, and brisk tendon reflexes. Brain imaging shows bilateral symmetric lesions in the basal ganglia. Lactate levels in serum and cerebrospinal fluid are increased. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV. Death in childhood may occur, often due to central respiratory failure.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
67.2 TPM
Artéria tibial
65.0 TPM
Aorta
63.9 TPM
Cólon sigmoide
62.4 TPM
Esôfago - Junção
60.0 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 1Charcot-Marie-Tooth disease type 4K
HGNC:11474UniProt:Q15526
MTMR2Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (4)
Synthesis of PIPs at the early endosome membraneSynthesis of PIPs at the late endosome membraneSynthesis of PIPs at the ER membraneSynthesis of PIPs at the plasma membrane
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 4B1

A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
27.3 TPM
Aorta
26.0 TPM
Artéria coronária
25.6 TPM
Testículo
25.4 TPM
Brain Spinal cord cervical c-1
24.0 TPM
OUTRAS DOENÇAS (1)
Charcot-Marie-Tooth disease type 4B1
HGNC:7450UniProt:Q13614
FGD4FYVE, RhoGEF and PH domain-containing protein 4Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (3)
G alpha (12/13) signalling eventsNRAGE signals death through JNKCDC42 GTPase cycle
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 4H

A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
21.7 TPM
Ovário
21.7 TPM
Nervo tibial
18.9 TPM
Tecido adiposo
16.5 TPM
Estômago
14.5 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
Charcot-Marie-Tooth disease type 4H
HGNC:19125UniProt:Q96M96
PRXPeriaxinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
EGR2 and SOX10-mediated initiation of Schwann cell myelination
MECANISMO DE DOENÇA

Dejerine-Sottas syndrome

A severe degenerating neuropathy of the demyelinating Charcot-Marie-Tooth disease category, with onset by age 2 years. Characterized by motor and sensory neuropathy with very slow nerve conduction velocities, increased cerebrospinal fluid protein concentrations, hypertrophic nerve changes, delayed age of walking as well as areflexia. There are both autosomal dominant and autosomal recessive forms of Dejerine-Sottas syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
707.6 TPM
Pulmão
61.5 TPM
Tireoide
19.0 TPM
Cervix Endocervix
11.2 TPM
Útero
10.6 TPM
OUTRAS DOENÇAS (2)
Charcot-Marie-Tooth disease type 4FCharcot-Marie-Tooth disease type 3
HGNC:13797UniProt:Q9BXM0
GDAP1Ganglioside-induced differentiation-associated protein 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Class I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 4A

A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. CMT4A is a severe form characterized by early age of onset and rapid progression leading to inability to walk in late childhood or adolescence.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
80.1 TPM
Brain Frontal Cortex BA9
56.7 TPM
Cerebelo
56.0 TPM
Pituitária
40.1 TPM
Brain Anterior cingulate cortex BA24
37.6 TPM
OUTRAS DOENÇAS (6)
Charcot-Marie-Tooth disease type 4ACharcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessiveCharcot-Marie-Tooth disease recessive intermediate ACharcot-Marie-Tooth disease axonal type 2K
HGNC:15968UniProt:Q8TB36
NDRG1Protein NDRG1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 4D

A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
816.8 TPM
Brain Spinal cord cervical c-1
440.5 TPM
Vagina
430.1 TPM
Esôfago - Mucosa
405.9 TPM
Skin Not Sun Exposed Suprapubic
403.3 TPM
OUTRAS DOENÇAS (1)
Charcot-Marie-Tooth disease type 4D
HGNC:7679UniProt:Q92597

Variantes genéticas (ClinVar)

488 variantes patogênicas registradas no ClinVar.

🧬 EGR2: NM_000399.5(EGR2):c.40C>T (p.Leu14Phe) ()
🧬 EGR2: NM_000399.5(EGR2):c.1226G>T (p.Arg409Leu) ()
🧬 EGR2: NM_000399.5(EGR2):c.1150C>A (p.His384Asn) ()
🧬 EGR2: NM_000399.5(EGR2):c.568T>A (p.Ser190Thr) ()
🧬 EGR2: NM_000399.5(EGR2):c.1414C>T (p.Arg472Trp) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 6.088 variantes classificadas pelo ClinVar.

913
913
4262
Patogênica (15.0%)
VUS (15.0%)
Benigna (70.0%)
VARIANTES MAIS SIGNIFICATIVAS
SH3TC2: NM_024577.4(SH3TC2):c.3426T>A (p.Tyr1142Ter) [Pathogenic]
LOC101928008: NM_030962.4(SBF2):c.1907del (p.Pro636fs) [Pathogenic]
SBF2: NM_030962.4(SBF2):c.115dup (p.Thr39fs) [Pathogenic]
PRX: NM_181882.3(PRX):c.2141T>C (p.Val714Ala) [Uncertain significance]
LOC101928008: NM_030962.4(SBF2):c.1930A>C (p.Lys644Gln) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença de Charcot-Marie-Tooth tipo 4

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
9 papers (10 anos)
#1

Increased BNIP3-mediated mitophagy attenuates GDAP1 loss of function - implications for Charcot-Marie-Tooth disease 4A.

Neurobiology of disease2025 Sep

Charcot-Marie-Tooth disease type 4 A ((CMT4A), an autosomal recessive neuropathy, is caused by mutations in ganglioside-induced differentiation-associated protein 1 (GDAP1). GDAP1 resides in the outer mitochondrial membrane facing the cytosol and is involved in mitochondrial dynamics and function. Its perturbation affects mitochondrial shape, contact sites, redox homeostasis and cellular metabolism. In response to GDAP1 knockdown in a human neuronal cell line, we found increased mitochondrial turnover, biogenesis and mitophagy. This was associated with more lysosomal proteins in mitochondrial fractions including BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) and its homolog BNIP3-like (BNIP3L) - proteins involved in the recruitment of autophagy machinery via direct interaction. Flies with neural Gdap1 knockdown also exhibited upregulated levels of the sole BNIP3 ortholog. Neural expression of human BNIP3 reduced the detrimental effects of Gdap1 knockdown on eclosion and climbing ability in adult flies, while simultaneous knockdown of both genes was detrimental. These findings suggest that increased BNIP3-driven mitophagy may act as a protective mechanism, partially counteracting the cellular dysfunction caused by GDAP1 loss of function, and highlight the potential of targeting mitophagy pathways as a therapeutic strategy for CMT4A.

#2

Chloroquine corrects enlarged lysosomes in FIG4 null cells and reduces neurodegeneration in Fig4 null mice.

Molecular genetics and metabolism2022 Dec

Loss-of-function mutations of FIG4 impair the biosynthesis of PI(3,5)P2 and are responsible for rare genetic disorders including Yunis-Varón Syndrome and Charcot-Marie-Tooth Disease Type 4 J. Cultured cells deficient in FIG4 accumulate enlarged lysosomes with hyperacidic pH, due in part to impaired regulation of lysosomal ion channels and elevated intra-lysosomal osmotic pressure. We evaluated the effects of the FDA approved drug chloroquine, which is known to reduce lysosome acidity, on FIG4 deficient cell culture and on a mouse model. Chloroquine corrected the enlarged lysosomes in FIG4 null cells. In null mice, addition of chloroquine to the drinking water slowed progression of the disorder. Growth and mobility were dramatically improved during the first month of life, and spongiform degeneration of the nervous system was reduced. The median survival of Fig4 null mice was increased from 4 weeks for untreated mutants to 8 weeks with chloroquine treatment (p < 0.009). Chloroquine thus corrects the lysosomal swelling in cultured cells and ameliorates Fig4 deficiency in vivo. The improved phenotype of mice with complete loss of Fig4 suggests that chloroquine could be beneficial FIG2 in partial loss-of-function disorders such as Charcot-Marie-Tooth Type 4 J.

#3

Investigation of Mutations in Exon 14 of SH3TC2 Gene and Exon 7 of NDRG1 Gene in Iranian Charcot-Marie-Tooth Disease Type 4 (CMT4D) Patients.

Iranian journal of child neurology2020

Charcot-Marie-tooth disease type 4 (CMT4D) is an autosomal recessive form of Charcot-Marie-tooth disease with an earlier age of onset and greater severity, compared to other types of this disease. CMT4C and CMT4D are the most prevalent subtypes in Mediterranean countries due to the higher rate of consanguineous marriage. In this study, we aimed to identify p.R148X mutation in NDRG1 gene and p.R1109X mutation in SH3TC2 gene (responsible for CMT4D and CMT4C, respectively) and to investigate other possible nucleotide changes in exon 14 of SH3TC2 gene and exon 7 of NDRG1 gene in an Iranian population. A total of 24 CMT4D patients, who were referred to Iran Special Medical Center, were clinically and electrophysiologically evaluated in this study. DNA was extracted from the patients' blood samples. Next, polymerase chain reaction (PCR) assay was carried out, and the products were sequenced and analyzed in FinchTV software. None of the target mutations were found in this study. Sequencing of SH3TC2 gene showed SNP rs1025476 (g.57975C>T) in 21 (87.5%) patients, including 7 homozygous and 14 heterozygous individuals. Despite the high rate of mutations in some populations, it seems that they are very rare in Iranian CMT4D patients. Regarding the association of SNP rs1025476 with CMT4D, further assessments are needed to reach a better understanding of genetic markers and their genetic features and to propose better diagnostic and treatment plans for the Iranian population.

#4

Mutational screening of the SH3TC2 gene in Greek patients with suspected demyelinating recessive Charcot-Marie-Tooth disease reveals a varied and unusual phenotypic spectrum.

Journal of the peripheral nervous system : JPNS2019 Mar

Charcot-Marie-Tooth disease type 4 C (CMT4C) is an autosomal recessive form of demyelinating peripheral neuropathy caused by mutations in SH3TC2, characterized by early onset, spine deformities, and cranial nerve involvement. We screened SH3TC2 in 50 unrelated Greek patients with suspected demyelinating Charcot-Marie-Tooth disease and pedigree compatible with recessive inheritance. All patients had been previously screened for PMP22, GJB1, and MPZ mutations. We found five previously identified pathogenic mutations in SH3TC2 distributed among 13 patients in homozygosity or compound heterozygosity (p. Arg954Stop, Arg1109Stop, Gln892Stop, Ala878Asp, and Arg648Trp). Although most cases had early onset and spine deformities were almost omnipresent, a wide phenotypic spectrum was observed. Particularly notable were two siblings with Roussy-Lévy syndrome and one patient with young-onset trigeminal neuralgia. In conclusion, mutations in SH3TC2 are responsible for 26% of Greek patients with suspected CMT4, identifying CMT4C as the most common recessive demyelinating neuropathy in the Greek population, in accordance with other Mediterranean cohorts.

#5

Heterozygosity for CMT Type 4 Predicts a Severe Vincristine-induced Polyneuropathy Phenotype: A Case Report and Review of Literature.

Journal of pediatric hematology/oncology2019 Jan

Vincristine (VCR) is a common chemotherapeutic agent used in the treatment of multiple types of pediatric tumors. VCR's adverse effects are well documented and commonly involve peripheral neuropathy via axonal degeneration. Neuropathic severity is dose-dependent, with sensory deficits occurring with as little as 4 mg cumulative dose. Severe peripheral neuropathy is generally rare, but its effects become additive when given to patients with undiagnosed hereditary peripheral neuropathy such as Charcot-Marie-Tooth. We report a case of an effect of VCR administration given to a patient who developed grade 4 neuropathy and was found to be a carrier of Charcot-Marie-Tooth disease type 4.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença de Charcot-Marie-Tooth tipo 4.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Doença de Charcot-Marie-Tooth tipo 4 e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

A CMT4 é uma forma genética e recessiva de polineuropatia sensório-motora periférica que danifica as fibras nervosas. Ela tem início na infância e provoca fraqueza muscular progressiva e deformidades nos pés.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

6 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:64749
    Orphanet
  2. GARD:12440
    GARD (NIH)
  3. Q3281259
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Doença de Charcot-Marie-Tooth tipo 4. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/doenca-de-charcot-marie-tooth-tipo-4

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Doença de Charcot-Marie-Tooth tipo 4

ORPHA:64749 · MONDO:0018995
Prevalência
1-5 / 10 000
Herança
Autosomal recessive
CID-11
Início
Childhood, Infancy
Prevalência
0.0 (Europe)
MedGen
UMLS
C4082197
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Rara